ESMO Breast Cancer is a congress designed for breast cancer researchers and clinicians who have a specific interest in innovation (including translational research, new agents, molecular and functional diagnostics, biomarkers and cutting-edge research.

Slides and webcasts are reserved to registered delegates.

ESMO Breast Cancer 2023 took place as a hybrid meeting, onsite in Berlin, Germany, on 11-13 May 2023, and online, through a virtual platform. .

.

.

Slides and webcasts are reserved to registered delegates. 07 - 09 Dec 2022. The ESMO Congress will take place in Madrid, 20-24.

Abstracts and ePosters are open access.

. . If an updated abstract with data and analyses is not submitted.

Administrative contacts need an ESMO account to register delegates to ESMO Asia Congress 2023. .

.

.

1">See more. Explore.

. 00 per delegate.

.
Access will open to ESMO Members on 11 Aug.
May 9, 2023 · ESMO Breast Cancer Congress 2023 Abstract Title: EMERALD trial analysis of patient-reported outcomes (PROs) in patients with ER+/HER2− advanced or metastatic breast cancer (mBC) comparing oral.

.

letter submission.

. Mark your calendars for the following abstract dates. Abstracts; Congress Officers.

Save the date for ESGO's 24th European Gynaecological Oncology Congress, from September 28-October 1, 2023, Istanbul, Türkiye. The use of these presentations is for personal educational purposes only. . May 11, 2023 · ESMO Breast Cancer 2023 took place as a hybrid meeting, onsite in Berlin, Germany, on 11-13 May 2023, and online, through a virtual platform. Abstract Number: LBA-1.

SGD 396.

. Abstracts; Congress Officers.

.

.

00 PM CET LATE-BREAKING ABSTRACTS: 12 APRIL 2023, 9.

In general, ASCO discourages reporting of interim analysis results, unless approved by the study’s Data and Safety Monitoring Committee.

.